| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.04 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.083 | 0.04 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.099 | 0.05 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |